{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:39:50Z","timestamp":1791430790977,"version":"4.3.3"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L376PA"],"award-info":[{"award-number":["L376PA"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["Z1AES103266"],"award-info":[{"award-number":["Z1AES103266"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Leeds Personal Fellowship","award":["RGCALA101195"],"award-info":[{"award-number":["RGCALA101195"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C6620\/A15961"],"award-info":[{"award-number":["C6620\/A15961"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C37059\/A18080"],"award-info":[{"award-number":["C37059\/A18080"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ccell.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T12:16:34Z","timestamp":1510575394000},"page":"701-715.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":280,"title":["Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency"],"prefix":"10.1016","volume":"32","author":[{"given":"Carolyn D.","family":"Hurst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Droop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy F.","family":"Stead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Burghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek J.","family":"Klimczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-An","family":"Roulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire F.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Thygesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Ridley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Gordenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2017.08.005_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/s12885-015-1859-8","article-title":"Determining the origin of synchronous multifocal bladder cancer by exome sequencing","volume":"15","author":"Acar","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ccell.2017.08.005_bib2","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"Chapter 7","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib3","doi-asserted-by":"crossref","first-page":"63252","DOI":"10.18632\/oncotarget.11207","article-title":"Target sequencing and CRISPR\/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer","volume":"7","author":"Ahn","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2017.08.005_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ng.2799","article-title":"Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy","volume":"45","author":"Balbas-Martinez","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"45","author":"Burns","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.08.005_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2017.08.005_bib9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ng.3378","article-title":"An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers","volume":"47","author":"Chan","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2017.08.005_bib11","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2017.08.005_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gr.134635.111","article-title":"MuSiC: identifying mutational significance in cancer genomes","volume":"22","author":"Dees","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib13","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2017.08.005_bib14","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1523\/JNEUROSCI.0778-09.2009","article-title":"Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner","volume":"29","author":"Di Nardo","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ccell.2017.08.005_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib16","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1158\/0008-5472.CAN-12-1329","article-title":"FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth","volume":"72","author":"Du","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib17","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.ccell.2017.08.005_bib18","article-title":"Comparative protein structure modeling using Modeller","volume":"Chapter 5","author":"Eswar","year":"2006","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ccell.2017.08.005_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00345-011-0709-9","article-title":"Impact of gender on bladder cancer incidence, staging, and prognosis","volume":"29","author":"Fajkovic","year":"2011","journal-title":"World J. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib20","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccell.2017.08.005_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cancergen.2015.01.005","article-title":"The cancer COMPASS: navigating the functions of MLL complexes in cancer","volume":"208","author":"Ford","year":"2015","journal-title":"Cancer Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"Futreal","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2017.08.005_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/1471-2164-13-505","article-title":"Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma","volume":"13","author":"Gartner","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ccell.2017.08.005_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/7.4.737","article-title":"The UTX gene escapes X inactivation in mice and humans","volume":"7","author":"Greenfield","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ng.2798","article-title":"Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation","volume":"45","author":"Guo","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib27","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"Gymnopoulos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2017.08.005_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","article-title":"Comprehensive transcriptional analysis of early-stage urothelial carcinoma","volume":"30","author":"Hedegaard","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2017.08.005_bib29","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"Hu","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccell.2017.08.005_bib30","first-page":"213","article-title":"RhoB in cancer suppression","volume":"21","author":"Huang","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ccell.2017.08.005_bib31","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1158\/1078-0432.CCR-12-1807","article-title":"Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis","volume":"18","author":"Hurst","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib32","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1021\/bi401216w","article-title":"Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB","volume":"52","author":"Hutchinson","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ccell.2017.08.005_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ucl.2013.01.004","article-title":"The costs of non-muscle invasive bladder cancer","volume":"40","author":"James","year":"2013","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.ccell.2017.08.005_bib34","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","article-title":"FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma","volume":"24","author":"Jebar","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2017.08.005_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2017.08.005_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib37","doi-asserted-by":"crossref","first-page":"e13821","DOI":"10.1371\/journal.pone.0013821","article-title":"FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy","volume":"5","author":"Kompier","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.08.005_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2017.08.005_bib39","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib40","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1158\/0008-5472.CAN-16-0436","article-title":"Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma","volume":"76","author":"Lamy","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib41","doi-asserted-by":"crossref","first-page":"eaai8312","DOI":"10.1126\/scitranslmed.aai8312","article-title":"Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2","volume":"9","author":"Ler","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2017.08.005_bib42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2017.08.005_bib43","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2017.08.005_bib44","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1158\/0008-5472.CAN-15-2629","article-title":"mTORC1-driven tumor cells are highly sensitive to therapeutic targeting by antagonists of oxidative stress","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib45","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1097-2765(00)80389-5","article-title":"The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN\/PRK1","volume":"4","author":"Maesaki","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2017.08.005_bib46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.21037\/tau.2016.03.22","article-title":"Female with bladder cancer: what and why is there a difference?","volume":"5","author":"Marks","year":"2016","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1541-7786.MCR-14-0440","article-title":"High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting","volume":"13","author":"Medvetz","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib48","doi-asserted-by":"crossref","first-page":"djv315","DOI":"10.1093\/jnci\/djv315","article-title":"BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers","volume":"108","author":"Meeks","year":"2016","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2017.08.005_bib49","doi-asserted-by":"crossref","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a network-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2017.08.005_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/00313021003767298","article-title":"Y chromosome loss is a frequent early event in urothelial bladder cancer","volume":"42","author":"Minner","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.ccell.2017.08.005_bib52","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2017.08.005_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","article-title":"Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis","volume":"29","author":"Ozcan","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2017.08.005_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1541-7786.MCR-13-0258-T","article-title":"Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide","volume":"12","author":"Parkhitko","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","author":"Pietzak","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib57","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1158\/1078-0432.CCR-09-0898","article-title":"Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer","volume":"15","author":"Platt","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present and future burden of urinary bladder cancer in the world","volume":"27","author":"Ploeg","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib59","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ccell.2017.08.005_bib60","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3678","article-title":"A new tumor suppressor role for the Notch pathway in bladder cancer","volume":"20","author":"Rampias","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2017.08.005_bib61","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib62","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2017.08.005_bib63","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib64","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/gim.2015.212","article-title":"Improving performance of multigene panels for genomic analysis of cancer predisposition","volume":"18","author":"Shirts","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ccell.2017.08.005_bib65","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sj\u00f6dahl","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12918","article-title":"The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis","volume":"7","author":"Starrett","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2017.08.005_bib67","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2017.08.005_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib70","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/hmg\/ddt589","article-title":"Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumor grade and stage and inversely related to chromosomal copy number changes","volume":"23","author":"Taylor","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BST0370433","article-title":"Mutation scanning using high-resolution melting","volume":"37","author":"Taylor","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ccell.2017.08.005_bib72","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/21681805.2016.1158207","article-title":"Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer","volume":"50","author":"Thorstenson","year":"2016","journal-title":"Scand. J. Urol."},{"key":"10.1016\/j.ccell.2017.08.005_bib73","doi-asserted-by":"crossref","first-page":"D889","DOI":"10.1093\/nar\/gkq857","article-title":"DAnCER: disease-annotated chromatin epigenetics resource","volume":"39","author":"Turinsky","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","article-title":"The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia","volume":"125","author":"Van der Meulen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2017.08.005_bib75","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/epi.28298","article-title":"The H3K27me3 demethylase UTX in normal development and disease","volume":"9","author":"Van der Meulen","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.ccell.2017.08.005_bib76","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"van Haaften","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2017.08.005_bib77","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/1078-0432.CCR-05-1045","article-title":"A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine","volume":"11","author":"van Oers","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2017.08.005_bib78","first-page":"511","article-title":"Expression profile of Rho kinases in urinary bladder cancer","volume":"16","author":"Volanis","year":"2011","journal-title":"J.\u00a0BUON"},{"key":"10.1016\/j.ccell.2017.08.005_bib79","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M114.555052","article-title":"Human UTY(KDM6C) is a male-specific N-methyl lysyl demethylase","volume":"289","author":"Walport","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2017.08.005_bib80","series-title":"Histological Typing of Urinary Bladder Tumours. International Histological Classification of Tumours 10","author":"WHO","year":"1973"},{"key":"10.1016\/j.ccell.2017.08.005_bib81","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2017.08.005_bib82","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1128\/MCB.21.16.5287-5298.2001","article-title":"The insert region of RhoA is essential for Rho kinase activation and cellular transformation","volume":"21","author":"Zong","year":"2001","journal-title":"Mol. Cell. Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817303483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610817303483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T23:18:24Z","timestamp":1542064704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610817303483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1535610817303483"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2017.08.005","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2017.08.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}